Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Columbia University
Celgene
Northwestern University
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Eastern Cooperative Oncology Group
Rhizen Pharmaceuticals SA
National Cancer Institute (NCI)
University of Texas Southwestern Medical Center
Celgene
Celgene
Celgene
Celgene
Celgene
Celgene
Celgene
Fondazione Italiana Linfomi - ETS
Northwestern University
Celgene
Takeda
Weill Medical College of Cornell University
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)